Open AccessSpHincterotomy for Acute Recurrent Pancreatitis Randomized Trial
Author(s) -
Gregory A. Coté,
Valerie DurkalskiMauldin,
José Serrano,
Erin Klintworth,
Alexus Williams,
Zobeida CruzMonserrate,
Mustafa A. Arain,
James Buxbaum,
Darwin L. Conwell,
Evan L. Fogel,
Martin L. Freeman,
Timothy B. Gardner,
Erwin van Geenen,
J. Royce Groce,
Sreenivasa S. Jonnalagadda,
Rajesh N. Keswani,
Shyam Me,
Dana C. Moffatt,
Georgios I. Papachristou,
Andrew Ross,
Paul R. Tarnasky,
Andrew Y. Wang,
C. Mel Wilcox,
Frank A. Hamilton,
Dhiraj Yadav
Publication year - 2019
Publication title -
pancreas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.061
H-Index - 104
eISSN - 1536-4828
pISSN - 0885-3177
DOI - 10.1097/mpa.0000000000001370
Subject(s) - pancreas divisum , medicine , endoscopic retrograde cholangiopancreatography , acute pancreatitis , pancreatitis , randomized controlled trial , endoscopic ultrasound , magnetic resonance cholangiopancreatography , sphincter of oddi dysfunction , major duodenal papilla , surgery , pancreatic duct
In patients with acute recurrent pancreatitis (ARP), pancreas divisum, and no other etiologic factors, endoscopic retrograde cholangiopancreatography (ERCP) with minor papilla endoscopic sphincterotomy (miES) is often performed to enlarge the minor papillary orifice, based on limited data. The aims of this study are to describe the rationale and methodology of a sham-controlled clinical trial designed to test the hypothesis that miES reduces the risk of acute pancreatitis.